Helen Loo Yau

Years Active: 2020-2021
Publications (10 Years): 2

University of Toronto (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Toronto Sep 01 2016

Canada

PHD :: Medical Biophysics

University of Toronto Sep 01 2013 - Jun 30 2016

Canada

MSC :: Medical Biophysics

University of Toronto Sep 01 2009 - Jun 30 2013

Canada

BSC :: Immunology

Publications

Kirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, Ben Wang, Shu Yi Shen, Ilias Ettayebi, Charles A Ishak, Philippe L Bedard, Albiruni Abdul Razak, Aaron R Hansen, Anna Spreafico, Dave Cescon, Marcus O Butler, Amit M Oza, Stephanie Lheureux, Neda Stjepanovic, Brendan Van As, Sarah Boross-Harmer, Lisa Wang, Trevor J Pugh, Pamela S Ohashi, Lillian L Siu, Daniel D De Carvalho
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors. Journal for immunotherapy of cancer 8 (2) (2021)
Parinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, Ankur Chakravarthy, Amir Hosseini, Yadong Wang, Fabíola Attié de Castro, Helen Loo Yau, Charles Ishak, Sagi Abelson, Catherine A O'Brien, Daniel D De Carvalho
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency. Nature 588 (7836) (2020)

Helen Loo Yau.css-eqlu8i{font-size:small;padding-left:4px;}